General Information of This Drug (ID: DM8QM5U)

Drug Name
Anidulafungin   DM8QM5U
Synonyms Ecalta; Eraxis; Anidulafungin [USAN:INN]; Ecalta (TN); Eraxis (TN); LY-303366; V-Echinocandin; VER-002
Indication
Disease Entry ICD 11 Status REF
Aspergillosis 1F20 Approved [1]
Candidiasis 1F23 Approved [2]
Convulsion 8A68.Z Approved [3]
Mycosis fungoides 2B01 Approved [1]
Neuroaspergillosis N.A. Approved [1]
Candidemia 1F23.3Y Investigative [1]
Coronavirus Disease 2019 (COVID-19) 1D6Y Investigative [4]
Esophageal candidiasis N.A. Investigative [1]
⏷ Show the Full List of Indication(s)
Therapeutic Class
Antifungal Agents
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

4 Clinical Trial Drug Combination(s) Consisting of This drug
DrugCom Name DrugCom ID Component Drug Indication REF
Anidulafungin + Fluconazole DCPOWF5 Fluconazole Candidemia [5]
Anidulafungin + Voriconazole DCY6XBV Voriconazole Aspergillosis [6]
Anidulafungin + Voriconazole DC8PJGI Voriconazole Fungal infection [7]
Anidulafungin + Voriconazole DCCNNIS Voriconazole Invasive Candidiasis [8]
------------------------------------------------------------------------------------

References

1 Anidulafungin FDA Label
2 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
3 Echinocandins: pharmacokinetic and therapeutic issues. Curr Med Res Opin. 2009 Jul;25(7):1741-50.
4 Suramin, Penciclovir and Anidulafungin bind nsp12, which governs the RNA-dependent-RNA polymerase activity of SARS-CoV-2, with higher interaction energy than Remdesivir, indicating potential in the treatment of Covid-19 infection. April.21.2020. Doi: 10.31219/osf.io/urxwh
5 ClinicalTrials.gov (NCT00761267) Study To Assess Pharmacokinetics, Safety & Efficacy of Anidulafungin When Treating Children With Invasive Candidiasis
6 ClinicalTrials.gov (NCT00531479) Anidulafungin Plus Voriconazole Versus Voriconazole For The Treatment Of Invasive Aspergillosis
7 Clinical pipeline report, company report or official report of Pfizer.
8 ClinicalTrials.gov (NCT00689338) Anidulafungin Candidemia/Invasive Candidiasis Intensive Care Study